Resources

Filter by:

Genetic study of von Willebrand factor antigen levels ≤ 50 IU/dL identifies variants associated with increased risk of von Willebrand disease and bleeding

Friedman RK, Heath AS, Huffman JE, Baker JT, Hasbani NR, Gagliano Taliun SA, Chen MH, Howard TE, Lewis JP, Pankratz N, Patil S, Reiner AP, Thibord F, Yanek LR,Jie Yao J, et al.
Von Willebrand Disease

Sexual and Reproductive Health in Sickle Cell Disease: A Qualitative Analysis of Pediatric Hematologist Perspectives

Oberoi AR, Clarke AR, Jacob SA, Kazmerski TM, Fassel H, Askew M, Woolford T, Karol Walec K, Leroy-Melamed M
Sickle Cell Disease

Safety and Efficacy Of Fertility Preservation in Sickle Cell Disease and Transfusion Dependent Thalassemia Patients Undergoing Gene Editing Therapies

Hmaidan S, Van Heertum K, Bhatia S, Frangoul H
Fertility Sickle Cell Disease

C-reactive protein and the menstrual cycle in females with sickle cell disease

Wu J, Veronica Bochenek V, Gollomp K, Roe AH,
Sickle Cell Disease

NASPAG Clinical Consensus: Use of Tranexamic Acid in the Treatment of Heavy Menstrual Bleeding

Lacy B, French A, Berger-Chen S, Shah-Bruce M, Haamid F
Heavy Menstrual Bleeding Recommendations & Guidelines

Health-related quality of life in rare bleeding disorders: results from the Rare Bleeding Disorders in the Netherlands study

Willems S, Cnossen MH, van Es N, den Exter PL, Kruis IC, Meijer K, Nieuwenhuizen L, Saes JL, Blijlevens N, van Heerde WL, Schols, E
Bleeding Disorders